Anna Babayan
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 10%
- Cancer Cells and Metastasis
Papers in
-
- Cancer Genomics and Diagnostics 6
- MicroRNA in disease regulation 2
-
- Epigenetics and DNA Methylation 1
- Glycosylation and Glycoproteins Research 1
- Co-authors
- Klaus Pantel (11 shared papers)George A. Călin (1 shared paper)Simone Anfossi (1 shared paper)Simon A. Joosse (5 shared papers)Volkmar Müller (4 shared papers)Juliane Hannemann (1 shared paper)Catherine Alix‐Panabières (2 shared papers)Laure Cayrefourcq (1 shared paper)
- Journals
- Cancers (2 papers)Oncotarget (2 papers)Clinical Chemistry (1 paper)PLoS ONE (1 paper)Nature Reviews Clinical Oncology (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Anna Babayan
12 papers receiving 745 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 470
- Oncology 254
- Molecular Biology 405
- Pulmonary and Respiratory Medicine 95
- Biomedical Engineering 85
Countries citing papers authored by Anna Babayan
This map shows the geographic impact of Anna Babayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Babayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Babayan more than expected).
Fields of papers citing papers by Anna Babayan
This network shows the impact of papers produced by Anna Babayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Babayan. The network helps show where Anna Babayan may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Babayan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 344 | |
| 2 | 2013 | 107 | |
| 3 | 2018 | 79 | |
| 4 | 2018 | 64 | |
| 5 | 2016 | 57 | |
| 6 | 2019 | 31 | |
| 7 | 2019 | 20 | |
| 8 | 2016 | 18 | |
| 9 | 2020 | 17 | |
| 10 | 2018 | 13 | |
| 11 | 2016 | 1 | |
| 12 | 2024 | 1 | |
| 13 | 2011 | 0 |
About Anna Babayan
Anna Babayan is a scholar working on Cancer Research, Molecular Biology, Oncology, Surgery and Pathology and Forensic Medicine, having authored 13 papers that have together received 752 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Cancer Cells and Metastasis (3 papers), MicroRNA in disease regulation (2 papers), Advanced Proteomics Techniques and Applications (1 paper), Epigenetics and DNA Methylation (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Microfluidic and Bio-sensing Technologies (1 paper). The work is most often cited by research in Cancer Research (470 citations), Oncology (254 citations), Molecular Biology (405 citations), Pulmonary and Respiratory Medicine (95 citations) and Biomedical Engineering (85 citations). Anna Babayan has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Klaus Pantel, George A. Călin, Simone Anfossi, Simon A. Joosse, Volkmar Müller, Juliane Hannemann, Catherine Alix‐Panabières, Laure Cayrefourcq, Saïd Assou and Eric Assénat. Their work appears in journals such as Cancers, Oncotarget, Clinical Chemistry, PLoS ONE and Nature Reviews Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.